
Bdenza Enzalutamide 40MG Tablets are non-steroidal antiandrogen agents that are used for treatment of prostate cancer. They are known to be highly effective for treating metastatic castration-resistant prostate cancer in combination with castration. These tablets are metabolized in liver by CYP2C8 and CYP3A4 with protein binding ability of 97 to 98%. Bdenza Enzalutamide 40MG Tablets are selective silent androgen receptor antagonists. They are second generation NSAA for having increased efficiency as an antiandrogen as compared to first generation compounds.
Features:
Highly effective in nature
Eliminated via bile and urine
Produces carboxylic acid derivatives as inactive metabolites
![]() |
SURETY HEALTHCARE
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |